Opportunity
Federal Register #2026-20552
DEA Regulatory Decision on Wellwise Pharmacy’s Controlled-Substance Registration
Buyer
Justice Department / Drug Enforcement Administration
Posted
October 07, 2026
Identifier
2026-20552
The U.S. Department of Justice’s Drug Enforcement Administration issued a regulatory decision concerning Wellwise Pharmacy Inc., not a procurement notice. - Government agency: U.S. Department of Justice (DOJ), Drug Enforcement Administration (DEA). - Entity named: Wellwise Pharmacy Inc., which operated in Houston and Conroe, Texas. - Decision: The DEA addressed Wellwise Pharmacy’s controlled-substance registration after citing repeated dispensing despite warning signs of possible abuse or diversion and violations of Texas pharmacy practice standards. The registration was immediately suspended, and the agency found grounds for revocation. - Procurement status: No products or services are requested, and no procurement vendors, OEMs, quantities, part numbers, or contract requirements are identified.
Description
The Drug Enforcement Administration issued a Decision and Order concerning Wellwise Pharmacy Inc., which operated in Houston and Conroe, Texas. The agency’s notice addresses the suspension and proposed revocation of the pharmacy’s DEA registration, based on allegations that it repeatedly dispensed controlled-substance prescriptions despite red flags of abuse or diversion and violations of Texas pharmacy practice standards. The source states that the registration was immediately suspended and that the agency found grounds to revoke it. This is an agency decision notice, not a procurement solicitation.